Incidence, Risk Factors, and Outcomes of Kidney Transplant Recipients Treated With Both Basiliximab and Antithymocyte Globulin:

Rachel Jeong,Robert R. Quinn,Krista L. Lentine,Pietro Ravani,Feng Ye,Patricia Campbell,Kevin Wen,Chris Broscheit,Sita Gourishankar,Ngan N. Lam

Incidence, Risk Factors, and Outcomes of Kidney Transplant Recipients Treated With Both Basiliximab and Antithymocyte Globulin:

2020

Rachel Jeong
Robert R. Quinn
Krista L. Lentine
Pietro Ravani
Feng Ye
Patricia Campbell
Kevin Wen
Chris Broscheit
Sita Gourishankar
Ngan N. Lam

Background:Kidney transplant recipients are given induction therapy to rapidly reduce the immune response and prevent rejection. Guidelines recommend that an interleukin-2 receptor antibody (basili...

Keywords:

kidney transplant
Immunology
induction therapy
Medicine
Thymoglobulin
Immune system
Globulin
Basiliximab
Receptor antibody
Immunosuppression

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations